Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 798426, 15 pages
http://dx.doi.org/10.1155/2015/798426
Review Article

Structure-Function Based Molecular Relationships in Ewing’s Sarcoma

Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Strasse, Building 21, 1113 Sofia, Bulgaria

Received 28 February 2014; Revised 30 August 2014; Accepted 14 October 2014

Academic Editor: Zoran Obradovic

Copyright © 2015 Roumiana Todorova. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. J. Law, K. L. Cann, and G. G. Hicks, “TLS, EWS and TAF15: a model for transcriptional integration of gene expression,” Briefings in Functional Genomics and Proteomics, vol. 5, no. 1, pp. 8–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Kovar, “Downstream EWS/FLI1—upstream Ewing's sarcoma,” Genome Medicine, vol. 2, no. 1, article 8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Ohno, M. Ouchida, L. Lee, Z. Gatalica, V. N. Rao, and E. S. P. Reddy, “The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains,” Oncogene, vol. 9, no. 10, pp. 3087–3097, 1994. View at Google Scholar · View at Scopus
  4. K. P. Ng, G. Potikyan, R. O. V. Savene, C. T. Denny, V. N. Uversky, and K. A. W. Lee, “Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 2, pp. 479–484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. P. Ng, K. K. Li, and K. A. Lee, “In vitro activity of the EWS oncogene transcriptional activation domain,” Biochemistry, vol. 48, no. 13, pp. 2849–2857, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. K. Andersson, A. Ståhlberg, Y. Arvidsson et al., “The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response,” BMC Cell Biology, vol. 9, article 37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Åman, I. Panagopoulos, C. Lassen et al., “Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS,” Genomics, vol. 37, no. 1, pp. 1–8, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. J. S. Felsch, W. S. Lane, and E. G. Peralta, “Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS,” Current Biology, vol. 9, no. 9, pp. 485–488, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. L. L. Knoop and S. J. Baker, “The splicing factor U1C represses EWS/FLI-mediated transactivation,” Journal of Biological Chemistry, vol. 275, no. 32, pp. 24865–24871, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. P. Paronetto, “Ewing sarcoma protein: a key player in human cancer,” International Journal of Cell Biology, vol. 2013, Article ID 642853, 12 pages, 2013. View at Publisher · View at Google Scholar
  11. J. Park, H. Kang, S. Kang et al., “A multifunctional protein, EWS, is essential for early brown fat lineage determination,” Developmental Cell, vol. 26, no. 4, pp. 393–404, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Zucman-Rossi, P. Legoix, J.-M. Victor, B. Lopez, and G. Thomas, “Chromosome translocation based on illegitimate recombination in human tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 20, pp. 11786–11791, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. S. L. Lessnick, B. S. Braun, C. T. Denny, and W. A. May, “Multiple domains mediate transformation by the Ewing's sarcoma EWS\FL1-1 fusion gene,” Oncogene, vol. 10, no. 3, pp. 423–431, 1995. View at Google Scholar · View at Scopus
  14. S. Jaishankar, J. Zhang, M. F. Roussel, and S. J. Baker, “Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity,” Oncogene, vol. 18, no. 40, pp. 5592–5597, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. K. L. Rossow and R. Janknecht, “The Ewing's sarcoma gene product functions as a transcriptional activator,” Cancer Research, vol. 61, no. 6, pp. 2690–2695, 2001. View at Google Scholar · View at Scopus
  16. S. Sankar and S. L. Lessnick, “Promiscuous partnerships in Ewing's sarcoma,” Cancer Genetics, vol. 204, no. 7, pp. 351–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Dosztányi, V. Csizmok, P. Tompa, and I. Simon, “IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content,” Bioinformatics, vol. 21, no. 16, pp. 3433–3434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Linding, L. J. Jensen, F. Diella, P. Bork, T. J. Gibson, and R. B. Russell, “Protein disorder prediction: implications for structural proteomics,” Structure, vol. 11, no. 11, pp. 1453–1459, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. R. Yang, R. Thomson, P. McNeil, and R. M. Esnouf, “RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins,” Bioinformatics, vol. 21, no. 16, pp. 3369–3376, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Xue, R. L. Dunbrack, R. W. Williams, A. K. Dunker, and V. N. Uversky, “PONDR-FIT: a meta-predictor of intrinsically disordered amino acids,” Biochimica et Biophysica Acta: Proteins and Proteomics, vol. 1804, no. 4, pp. 996–1010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. V. N. Uversky, C. J. Oldfield, U. Midic et al., “Unfoldomics of human diseases: linking protein intrinsic disorder with diseases,” BMC Genomics, vol. 10, no. 1, article S7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Liu, N. B. Perumal, C. J. Oldfield, E. W. Su, V. N. Uversky, and A. K. Dunker, “Intrinsic disorder in transcription factors,” Biochemistry, vol. 45, no. 22, pp. 6873–6888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Hegyi, L. Buday, and P. Tompa, “Intrinsic structural disorder confers cellular viability on oncogenic fusion proteins,” PLoS Computational Biology, vol. 5, no. 10, Article ID e1000552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Spahn, C. Siligan, R. Bachmaier, J. A. Schmid, D. N. T. Aryee, and H. Kovar, “Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein,” Oncogene, vol. 22, no. 44, pp. 6819–6829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Üren, O. Tcherkasskaya, and J. A. Toretsky, “Recombinant EWS-FLI1 oncoprotein activates transcription,” Biochemistry, vol. 43, no. 42, pp. 13579–13589, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Todorova, “Disorder structural predictions of the native EWS and its oncogenic fusion proteins in rapport with the function,” Advances of Biosciences and Biotechnology, vol. 3, pp. 25–34, 2012. View at Google Scholar
  27. R. Todorova, “Disordered binding regions of Ewing's sarcoma fusion proteins,” Russian Journal of Bioorganic Chemistry, vol. 40, no. 1, pp. 16–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Bertolotti, T. Melot, J. Acker, M. Vigneron, O. Delattre, and L. Tora, “EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the tet family, EWS and HTAF(II)68, and subunits of TFIID and RNA polymerase II complexes,” Molecular and Cellular Biology, vol. 18, no. 3, pp. 1489–1497, 1998. View at Google Scholar · View at Scopus
  29. G. Nilsson, M. Wang, J. Wejde, A. Kreicbergs, and O. Larsson, “Detection of EWS/FLI-1 by immunostaining. An adjunctive tool in diagnosis of Ewing's sarcoma and primitive neuroectodermal tumour on cytological samples and paraffin-embedded archival material,” Sarcoma, vol. 3, no. 1, pp. 25–32, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Jishage, T. Fujino, Y. Yamazaki, H. Kuroda, and T. Nakamura, “Identification of target genes for EWS/ATF-1 chimeric transcription factor,” Oncogene, vol. 22, no. 1, pp. 41–49, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Song, S. C. Ng, P. Tompa, K. A. W. Lee, and H. S. Chan, “Polycation-π interactions are a driving force for molecular recognition by an intrinsically disordered oncoprotein family,” PLoS Computational Biology, vol. 9, no. 9, Article ID e1003239, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. L. L. Belyanskaya, P. M. Gehrig, and H. Gehring, “Exposure on cell surface and extensive arginine methylation of ewing sarcoma (EWS) protein,” The Journal of Biological Chemistry, vol. 276, no. 22, pp. 18681–18687, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Pahlich, L. Quero, B. Roschitzki, R. P. Leemann-Zakaryan, and H. Gehring, “Analysis of Ewing Sarcoma (EWS)-binding proteins: interaction with hnRNP M, U, and RNA-helicases p68/72 within protein-RNA complexes,” Journal of Proteome Research, vol. 8, no. 10, pp. 4455–4465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Kanai, N. Dohmae, and N. Hirokawa, “Kinesin transports RNA: isolation and characterization of an RNA-transporting granule,” Neuron, vol. 43, no. 4, pp. 513–525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Lee, J. Sayegh, J. Daniel, S. Clarke, and M. T. Bedford, “PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family,” The Journal of Biological Chemistry, vol. 280, no. 38, pp. 32890–32896, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. H. J. Lee, S. Kim, J. Pelletier, and J. Kim, “Stimulation of hTAFII68 (NTD)-mediated transactivation by v-Src,” FEBS Letters, vol. 564, no. 1-2, pp. 188–198, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Pahlich, R. P. Zakaryan, and H. Gehring, “Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state,” Proteins: Structure, Function and Genetics, vol. 72, no. 4, pp. 1125–1137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Schlottmann, H. V. Erkizan, J. Barber-Rotenberg et al., “EWS-FLI1 is regulated by acetylation,” in Proceedings of the 101st Annual Meeting of the American Association for Cancer Research (AACR '10), p. 3897, Washington, DC, USA, 2010.
  39. M. Perani, P. Antonson, R. Hamoudi et al., “The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins,” Journal of Biological Chemistry, vol. 280, no. 52, pp. 42863–42876, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Liu, H. Cheng, W. Kwan, J. M. Lubieniecka, and T. O. Nielsen, “Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models,” Molecular Cancer Therapeutics, vol. 7, no. 6, pp. 1751–1761, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Carrère, A. Verger, A. Flourens, D. Stehelin, and M. Duterque-Coquillaud, “Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains,” Oncogene, vol. 16, no. 25, pp. 3261–3268, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Baskaran, M. E. Dahmus, and J. Y. J. Wang, “Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11167–11171, 1993. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Kim, J. M. Lee, P. E. Branton, and J. Pelletier, “Modification of EWS/WT1 functional properties by phosphorylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 25, pp. 14300–14305, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Pan, K. Y. Ming, T. A. Dunn, K. K. C. Li, and K. A. W. Lee, “The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly,” Oncogene, vol. 16, no. 12, pp. 1625–1631, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. S. L. Heyerdahl, J. Rozenberg, L. Jamtgaard et al., “The arylstibonic acid compound NSC13746 disrupts B-ZIP binding to DNA in living cells,” European Journal of Cell Biology, vol. 89, no. 7, pp. 564–573, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Yang, H.-M. Hu, A. Zielinska-Kwiatkowska, and H. A. Chansky, “FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells,” Biochemical and Biophysical Research Communications, vol. 402, no. 1, pp. 129–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Ravasi, H. Suzuki, C. V. Cannistraci et al., “An atlas of combinatorial transcriptional regulation in mouse and man,” Cell, vol. 140, no. 5, pp. 744–752, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Deneen, H. Hamidi, and C. T. Denny, “Functional analysis of the EWS/ETS target gene uridine phosphorylase,” Cancer Research, vol. 63, no. 14, pp. 4268–4274, 2003. View at Google Scholar · View at Scopus
  49. K. A. France, J. L. Anderson, A. Park, and C. T. Denny, “Oncogenic fusion protein EWS/FLI1 down-regulates gene expression by both transcriptional and posttranscriptional mechanisms,” The Journal of Biological Chemistry, vol. 286, no. 26, pp. 22750–22757, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. H. A. Chansky, M. Hu, D. D. Hickstein, and L. Yang, “Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein,” Cancer Research, vol. 61, no. 9, pp. 3586–3590, 2001. View at Google Scholar · View at Scopus
  51. D. Zhang, A. J. Paley, and G. Childs, “The transcriptional repressor, ZFM1 interacts with and modulates the ability of EWS to activate transcription,” Journal of Biological Chemistry, vol. 273, no. 29, pp. 18086–18091, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Oyoshi and R. Kurokawa, “Structure of noncoding RNA is a determinant of function of RNA binding proteins in transcriptional regulation,” Cell and Bioscience, vol. 2, no. 1, article 1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. J. A. Toretsky, V. Erkizan, A. Levenson et al., “Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A,” Cancer Research, vol. 66, no. 11, pp. 5574–5581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. H. V. Erkizan, Y. Kong, M. Merchant et al., “A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma,” Nature Medicine, vol. 15, no. 7, pp. 750–756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. H. V. Erkizan, V. N. Uversky, and J. A. Toretsky, “Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma,” Clinical Cancer Research, vol. 16, no. 16, pp. 4077–4083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Iwamoto, “Diagnosis and treatment of Ewing's sarcoma,” Japanese Journal of Clinical Oncology, vol. 37, no. 2, pp. 79–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Stoll, D. Surdez, F. Tirode et al., “Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis,” Nucleic Acids Research, vol. 41, no. 19, pp. 8853–8871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Sankar, R. Bell, B. Stephens et al., “Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma,” Oncogene, vol. 32, no. 42, pp. 5089–5100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. N. Toor, K. S. Keating, S. D. Taylor, and A. M. Pyle, “Crystal structure of a self-spliced group II intron,” Science, vol. 320, no. 5872, pp. 77–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Dutertre, G. Sanchez, M.-C. de Cian et al., “Cotranscriptional exon skipping in the genotoxic stress response,” Nature Structural and Molecular Biology, vol. 17, no. 11, pp. 1358–1366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. M. P. Paronetto, B. Miñana, and J. Valcárcel, “The Ewing sarcoma protein regulates DNA damage-induced alternative splicing,” Molecular Cell, vol. 43, no. 3, pp. 353–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Hirose and J. L. Manley, “RNA polymerase II and the integration of nuclear events,” Genes & Development, vol. 14, no. 12, pp. 1415–1429, 2000. View at Google Scholar · View at Scopus
  63. S. P. Somasekharan, N. Stoynov, B. Rotblat et al., “Identification and quantification of newly synthesized proteins translationally regulated by YB-1 using a novel Click-SILAC approach,” Journal of Proteomics, vol. 77, pp. e1–e10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. D. N. Lyabin, A. N. Doronin, I. A. Eliseeva et al., “Alternative Forms of Y-Box Binding Protein 1 and YB-1 mRNA,” PLoS ONE, vol. 9, no. 8, Article ID e104513, 2014. View at Google Scholar
  65. L. Yang, H. A. Chansky, and D. D. Hickstein, “EWS·Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing,” The Journal of Biological Chemistry, vol. 275, no. 48, pp. 37612–37618, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Herrero-Martin, A. Fourtouna, S. Niedan, L. T. Riedmann, R. Schwentner, and D. N. T. Aryee, “Factors affecting EWS-FLI1 activity in Ewing's sarcoma,” Sarcoma, vol. 2011, Article ID 352580, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. J. L. Anderson, C. T. Denny, W. D. Tap, and N. Federman, “Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities,” Pediatric Research, vol. 72, no. 2, pp. 112–121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. G. Sanchez, O. Delattre, D. Auboeuf, and M. Dutertre, “Coupled alteration of transcription and splicing by a single oncogene: boosting the effect on cyclin D1 activity,” Cell Cycle, vol. 7, no. 15, pp. 2299–2305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. L. Dylla, C. Moore, and P. Jedlicka, “MicroRNAs in Ewing sarcoma,” Frontiers in Oncology, vol. 3, article 65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Nakajima, C. Uchida, S. F. Anderson et al., “RNA helicase A mediates association of CBP with RNA polymerase II,” Cell, vol. 90, no. 6, pp. 1107–1112, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Spahn, R. Petermann, C. Siligan, J. A. Schmid, D. N. T. Aryee, and H. Kovar, “Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway,” Cancer Research, vol. 62, no. 16, pp. 4583–4587, 2002. View at Google Scholar · View at Scopus
  72. H. Li, W. Watford, C. Li et al., “Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1314–1323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. R. A. Young, “RNA polymerase II,” Annual Review of Biochemistry, vol. 60, pp. 689–715, 1991. View at Publisher · View at Google Scholar · View at Scopus
  74. D. A. Bushnell and R. D. Kornberg, “Complete, 12-subunit RNA polymerase II at 4.1-Å resolution: implications for the initiation of transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 6969–6973, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Choder, “Rpb4 and Rpb7: subunits of RNA polymerase II and beyond,” Trends in Biochemical Sciences, vol. 29, no. 12, pp. 674–681, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Petermann, B. M. Mossier, D. N. T. Aryee, V. Khazak, E. A. Golemis, and H. Kovar, “Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II,” Oncogene, vol. 17, no. 5, pp. 603–610, 1998. View at Publisher · View at Google Scholar · View at Scopus
  77. R. Todorova, “In vitro interaction between the N-terminus of the Ewing's sarcoma protein and the subunit of RNA polymerase II hsRPB7,” Molecular Biology Reports, vol. 36, no. 6, pp. 1269–1274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. X. Na, H. O. Duan, E. M. Messing et al., “Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein,” The EMBO Journal, vol. 22, no. 16, pp. 4249–4259, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Zhou and K. A. W. Lee, “An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene,” Oncogene, vol. 20, no. 12, pp. 1519–1524, 2001. View at Publisher · View at Google Scholar · View at Scopus
  80. N. Corbi, M. Di Padova, R. De Angelis et al., “The α-like RNA polymerase II core subunit 3 (RPB3) is involved in tissue-specific transcription and muscle differentiation via interaction with the myogenic factor myogenin,” The FASEB Journal, vol. 16, no. 12, pp. 1639–1641, 2002. View at Google Scholar · View at Scopus
  81. B. Plougastel, J. Zucman, M. Peter, G. Thomas, and O. Delattre, “Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation,” Genomics, vol. 18, no. 3, pp. 609–615, 1993. View at Publisher · View at Google Scholar · View at Scopus
  82. G. F. Riccardi, C. Stein, G. de la Roza, and T. A. Damron, “Newly described translocation (18;19)(q23;q13.2) in abdominal wall soft-tissue tumor resembling Ewing sarcoma/primitive neuroectodermal tumor,” Cancer Genetics and Cytogenetics, vol. 201, no. 1, pp. 1–5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. D. J. Shaw, R. Morse, A. G. Todd, P. Eggleton, C. L. Lorson, and P. J. Young, “Identification of a self-association domain in the Ewing's sarcoma protein: a novel function for arginine-glycine-glycine rich motifs?” Journal of Biochemistry, vol. 147, no. 6, pp. 885–893, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. P. Cramer, D. A. Bushnell, and R. D. Kornberg, “Structural basis of transcription: RNA polymerase II at 2.8 Ångstrom resolution,” Science, vol. 292, no. 5523, pp. 1863–1876, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. N. A. Woychik and M. Hampsey, “The RNA polymerase II machinery: structure illuminates function,” Cell, vol. 108, no. 4, pp. 453–463, 2002. View at Publisher · View at Google Scholar · View at Scopus
  86. R. Todorova, “Functional interactions in transcription and splicing of Ewing’s sarcoma,” ISRN Genetics, vol. 2013, Article ID 184063, 6 pages, 2013. View at Publisher · View at Google Scholar
  87. H. V. Erkizan, L. J. Scher, S. E. Gamble et al., “Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors,” Cell Cycle, vol. 10, no. 19, pp. 3397–3408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. S.-H. Hong, S. E. Youbi, S. Peter Hong et al., “Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in ewing sarcoma,” Oncotarget, vol. 5, no. 2, pp. 338–350, 2014. View at Google Scholar · View at Scopus
  89. S. Schlottmann, H. V. Erkizan, J. S. Barber-Rotenberg et al., “Acetylation increases EWS-FLI1 DNA binding and transcriptional activity,” Frontiers in Oncology, vol. 2, Article ID Article 107, p. 107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. J. U. Tilan, C. Lu, S. Galli et al., “Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects,” Oncotarget, vol. 4, no. 12, pp. 2487–2501, 2013. View at Google Scholar · View at Scopus
  91. S.-I. Do, E. S. Araujo, R. K. Kalil et al., “Expression of embryonic lethal abnormal vision (ELAV)-like protein HuR and cyclooxygenase-2 (COX-2) in Ewing sarcoma,” Tumori, vol. 94, no. 3, pp. 347–350, 2008. View at Google Scholar · View at Scopus